We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWACW
226
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
$103K 0.01%
1,713,449
+167,852
+11% +$20.8K
FSSIW
227
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$103K 0.01%
820,977
-58,450
-7% -$14K
CRHC.WS
228
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$102K 0.01%
+238,287
New +$173K
LVS icon
229
CALL
Las Vegas Sands
LVS
$29.4B
$101K 0.01%
+25,000
New +$865K
WPCA.WS
230
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$99K 0.01%
319,887
+200,673
+168% +$92.2K
AMZN icon
231
CALL
Amazon
AMZN
$3T
$96K 0.01%
+142,500
New +$17.8M
SDSTW
232
Stardust Power Inc Warrant
SDSTW
$96K 0.01%
535,997
+223,365
+71% +$63.9K
ASZ.WS
233
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$95K 0.01%
775,844
-195,956
-20% -$75K
MAPS
234
DELISTED
WM TECHNOLOGY INC A
MAPS
$94K 0.01%
28,562
TEVA icon
235
CALL
Teva Pharmaceuticals
TEVA
$42.1B
$94K 0.01%
223,800
PDYNW icon
236
Palladyne AI Corp Warrants
PDYNW
$169K
$94K 0.01%
+199,189
New +$133K
WINVW
237
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$92K 0.01%
1,019,737
+64,322
+7% +$7.77K
ATVI
238
PUT
DELISTED
Activision Blizzard
ATVI
$92K 0.01%
20,600
-41,100
-67% -$3.2M
VTIQW
239
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$90K 0.01%
409,568
-48,368
-11% -$18.1K
PRPC.WS
240
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$88K 0.01%
293,041
-26,042
-8% -$11.8K
AAC.WS
241
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$88K 0.01%
381,884
+252,175
+194% +$78.2K
TSPQ.WS
242
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$87K 0.01%
396,982
+264,018
+199% +$65.7K
LAZR
243
CALL
DELISTED
Luminar Technologies
LAZR
$86K 0.01%
+42,913
New +$6.86M
MLTX icon
244
MoonLake Immunotherapeutics
MLTX
$1.47B
$85K 0.01%
+16,173
New +$102K
GAQ.WS
245
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$82K 0.01%
422,898
-1,400
-0.3% -$333
AQST icon
246
Aquestive Therapeutics
AQST
$538M
$80K 0.01%
+124,590
New +$166K
WOW
247
PUT
DELISTED
WideOpenWest
WOW
$79K 0.01%
+28,500
New +$573K
FINMW
248
DELISTED
Marlin Technology Corporation Warrant
FINMW
$78K 0.01%
706,079
+544,726
+338% +$116K
TALKW
249
DELISTED
Talkspace Inc Warrant
TALKW
$77K 0.01%
220,587
-1,648
-0.7% -$384
CNDA.WS
250
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$77K 0.01%
349,844
+29,966
+9% +$10.8K

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.